Enhancement of primary total joint arthroplasty (TJA) clinical and surgical protocols, cost containment and value-based healthcare initiatives, removal of total hip and knee arthroplasty from Medicare’s Inpatient-Only list, and the COVID-19 pandemic have coalesced to promote and expand the rapid growth of outpatient TJA. Identification of patients who can safely undergo outpatient TJA remains a top priority for which conclusive evidence has yet to be definitively established.
